Data-driven approaches for tau-PET imaging biomarkers in Alzheimer's disease (Q58120970)

9

Philip Scheltens

0 references

Oskar Hansson

12

Oskar Hansson

0 references

Niklas Mattsson

2

Niklas Mattsson

0 references

Rik Ossenkoppele

13

Rik Ossenkoppele

0 references

Alan C. Evans

11

Alan C. Evans

0 references

Pierre Bellec

10

Pierre Bellec

0 references

author name string

Jacob W Vogel

1

0 references

Yasser Iturria-Medina

3

0 references

Olof T Strandberg

4

0 references

Michael Schöll

5

0 references

Christian Dansereau

6

0 references

Sylvia Villeneuve

7

0 references

Wiesje M van der Flier

8

0 references

Jacob W. Vogel

1

0 references

Olof T. Strandberg

4

0 references

Wiesje M. van der Flier

describes a project that uses

8

0 references

language of work or name

English

0 references

publication date

19 October 2018

0 references

number of pages

14

0 references

published in

Human Brain Mapping

0 references

volume

40

0 references

page(s)

638-651

0 references

issue

2

0 references

scikit-image

1 reference

Europe PubMed Central

8 June 2022

https://europepmc.org/search?query=(METHODS:'scikit-image')

inferred from PubMed Central ID database lookup

1 reference

7 January 2021

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

1 reference

7 January 2021

Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease.

1 reference

7 January 2021

Identification of large-scale networks in the brain using fMRI.

1 reference

7 January 2021

Multi-level bootstrap analysis of stable clusters in resting-state fMRI.

1 reference

7 January 2021

Neuropathological stageing of Alzheimer-related changes

1 reference

7 January 2021

Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807.

1 reference

7 January 2021

In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum.

1 reference

7 January 2021

Excessive tau accumulation in the parieto-occipital cortex characterizes early-onset Alzheimer's disease.

1 reference

7 January 2021

Off-Target 18F-AV-1451 Binding in the Basal Ganglia Correlates with Age-Related Iron Accumulation.

1 reference

7 January 2021

Development and assessment of a composite score for memory in the Alzheimer's Disease Neuroimaging Initiative (ADNI)

1 reference

7 January 2021

An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest

1 reference

7 January 2021

Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults

1 reference

7 January 2021

The measurement of everyday cognition (ECog): scale development and psychometric properties

1 reference

7 January 2021

1 reference

7 January 2021

Combining multiple clusterings using evidence accumulation.

1 reference

7 January 2021

Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers

1 reference

7 January 2021

TEMPORARY REMOVAL: Detecting stable individual differences in the functional organization of the human basal ganglia.

1 reference

7 January 2021

In vivo staging of regional amyloid deposition

1 reference

7 January 2021

Tau Pathology Distribution in Alzheimer's disease Corresponds Differentially to Cognition-Relevant Functional Brain Networks

1 reference

7 January 2021

Correlations of (18)F-THK5351 PET with post-mortem burden of tau and astrogliosis in Alzheimer's disease.

1 reference

7 January 2021

Tau pathology and cognitive reserve in Alzheimer's disease.

1 reference

7 January 2021

A new clinical scale for the staging of dementia.

1 reference

7 January 2021

[F-18]AV-1451 positron emission tomography retention in choroid plexus: More than "off-target" binding

1 reference

7 January 2021

Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis

1 reference

7 January 2021

Tau positron emission tomographic imaging in aging and early Alzheimer disease

1 reference

7 January 2021

Tau, amyloid, and cascading network failure across the Alzheimer's disease spectrum.

1 reference

7 January 2021

Circular analysis in systems neuroscience: the dangers of double dipping

1 reference

7 January 2021

Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI.

1 reference

7 January 2021

Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β-amyloid

1 reference

7 January 2021

Elevated 18F-AV-1451 PET tracer uptake detected in incidental imaging findings

1 reference

7 January 2021

An autoradiographic evaluation of AV-1451 Tau PET in dementia

1 reference

7 January 2021

Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease

1 reference

7 January 2021

Entorhinal tau pathology, episodic memory decline and neurodegeneration in aging.

1 reference

7 January 2021

Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue

1 reference

7 January 2021

[F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging.

1 reference

7 January 2021

Amyloid plaque core protein in Alzheimer disease and Down syndrome

1 reference

7 January 2021

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

1 reference

7 January 2021

AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: Defining a summary measure

1 reference

7 January 2021

Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature

1 reference

7 January 2021

Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain

1 reference

7 January 2021

The Richness of Task-Evoked Hemodynamic Responses Defines a Pseudohierarchy of Functionally Meaningful Brain Networks

1 reference

7 January 2021

Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.

1 reference

7 January 2021

Effects of imaging modalities, brain atlases and feature selection on prediction of Alzheimer's disease

1 reference

7 January 2021

Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease

1 reference

7 January 2021

Data-driven regions of interest for longitudinal change in frontotemporal lobar degeneration

1 reference

7 January 2021

Measurement of functional activities in older adults in the community.

1 reference

7 January 2021

A new rating scale for Alzheimer's disease.

1 reference

7 January 2021

How golden is the gold standard of neuropathology in dementia?

1 reference

7 January 2021

PET Imaging of Tau Deposition in the Aging Human Brain.

1 reference

7 January 2021

Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages.

1 reference

7 January 2021

Hierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex

1 reference

7 January 2021

Increased basal ganglia binding of 18 F-AV-1451 in patients with progressive supranuclear palsy.

1 reference

7 January 2021

Cognitive reserve in ageing and Alzheimer's disease.

1 reference

7 January 2021

Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease.

1 reference

7 January 2021

[(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease

1 reference

7 January 2021

Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease.

1 reference

7 January 2021

Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/30368979

12 December 2020